Physician profile
David J Wang
NPI 1942341912
$3,906.17
in general payments reported to CMS, 2019-2025
22 companies · $2,705 in 2025
The $2,705 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $11.13 · 2022: $121 · 2023: $570 · 2024: $53.44 · 2025: $2,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,400 · Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,400.00 |
| Food and Beverage | $928.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beone Medicines USA, INC. | $2,400.00 | 2025 | Tevimbra |
| Boston Scientific Corporation | $385.31 | 2023-2025 | Watchman Flx, General - Vascular Intervention, Ekosonic |
| Novartis Pharmaceuticals Corporation | $223.08 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.68 | 2019-2025 | Lifevest |
| Biotronik INC. | $136.82 | 2023 | Biomonitor |
| Atricure, INC. | $131.92 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $114.17 | 2019 | |
| Heartflow, INC. | $80.52 | 2023 | Ffrct |
| Pfizer INC. | $62.27 | 2019-2023 | |
| Amgen INC. | $57.07 | 2019-2022 | |
| Philips North America LLC | $45.48 | 2023 | |
| Inspire Medical Systems, INC. | $23.23 | 2025 | Inspire |
| Medtronic, INC. | $19.58 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.89 | 2023 | Jardiance |
| Akcea Therapeutics, INC. | $16.29 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $15.76 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.34 | 2019 | |
| Abbott Laboratories | $13.12 | 2019 | |
| Tactile Systems Technology INC | $12.64 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.